These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 744053)

  • 1. Lack of effect of hypomagnesemia on elevated plasma 1,25-dihydroxycholecalciferol in acutely phosphate-deprived rats.
    Kurokawa K; Haussler MR
    Endocrinology; 1978 Jun; 102(6):1864-6. PubMed ID: 744053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 1alpha,25-dihydroxyvitamin D3 and Solanum glaucophyllum on intestinal calcium and phosphate transport and on plasma Ca, Mg and P levels in the rat.
    Walling MW; Kimberg DV
    Endocrinology; 1975 Dec; 97(6):1567-76. PubMed ID: 1204578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum 1,25-dihydroxycholecalciferol in anephric, haemodialyzed and kidney-transplanted patients. Effect of vitamin D3 supplement.
    Lund B; Clausen E; Friedberg M; Lund B; Moszkowicz M; Nielsen SP; Sørensen OH
    Nephron; 1980; 25(1):30-3. PubMed ID: 6243405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism.
    Gray RW; Wilz DR; Caldas AE; Lemann J
    J Clin Endocrinol Metab; 1977 Aug; 45(2):299-306. PubMed ID: 885994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary phosphate deprivation increases renal synthesis and decreases renal catabolism of 1,25-dihydroxycholecalciferol in guinea pigs.
    Simboli-Campbell M; Jones G
    J Nutr; 1991 Oct; 121(10):1635-42. PubMed ID: 1765829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assay of 1alpha,25-dihydroxyvitamin D3: physiologic and pathologic modulation of circulating hormone levels.
    Haussler MR; Baylink DJ; Hughes MR; Brumbaugh PF; Wergedal JE; Shen FH; Nielsen RL; Counts SJ; Bursac KM; McCain TA
    Clin Endocrinol (Oxf); 1976; 5 Suppl():151S-165S. PubMed ID: 212227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25 dihydroxycholecalciferol treatment of uraemic rats after high magnesium feeding.
    Binswanger U; Schiffl H; Huggler M; Becker C
    Proc Eur Dial Transplant Assoc; 1980; 17():563-8. PubMed ID: 6894642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.
    Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H
    J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ionic control of 1,25-dihydroxyvitamin D3 production in isolated chick renal tubules.
    Bikle DD; Rasmussen H
    J Clin Invest; 1975 Feb; 55(2):292-8. PubMed ID: 236326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum levels of 1alpha, 25-dihydroxycholecalciferol in lactating rats.
    Boass A; Toverud SU; McCain TA; Pike JW; Haussler MR
    Nature; 1977 Jun; 267(5612):630-2. PubMed ID: 876385
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
    Gonzalez-Villapando C; Porath A; Berelowitz M; Marshall L; Favus MJ
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1180-3. PubMed ID: 6893459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response to 1,25-dihydroxycholecalciferol and to dihydrotachysterol in adult-onset hypophosphataemic osteomalacia.
    Ahmed KY; Varghese Z; Moorhead JF; Wills MR
    Clin Chim Acta; 1979 Sep; 97(1):33-7. PubMed ID: 315284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of protracted neonatal hypocalcaemia to 1alpha,25-dihydroxyvitamin D3.
    Kooh SW; Fraser D; Toon R; DeLuca HF
    Lancet; 1976 Nov; 2(7995):1105-7. PubMed ID: 62947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dietary calcium, phosphate and vitamin D deprivation on the pharmacokinetics of 1,25-dihydroxyvitamin D3 in the rat.
    Jongen MJ; Bishop JE; Cade C; Norman AW
    Horm Metab Res; 1987 Oct; 19(10):481-5. PubMed ID: 3428866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competition by 24,25-dihydroxycholecalciferol in the competitive protein binding radioassay of 25-hydroxycalciferol.
    Haddad JG; Min C; Walgate J; Hahn T
    J Clin Endocrinol Metab; 1976 Sep; 43(3):712-5. PubMed ID: 956355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal vitamin D metabolism in the X-linked hypophosphatemic mouse.
    Meyer RA; Gray RW; Meyer MH
    Endocrinology; 1980 Nov; 107(5):1577-81. PubMed ID: 6893581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma 1,25-(OH)2-vitamin D concentrations and net intestinal calcium, phosphate, and magnesium absorption in humans.
    Wilz DR; Gray RW; Dominguez JH; Lemann J
    Am J Clin Nutr; 1979 Oct; 32(10):2052-60. PubMed ID: 484524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development-related regulation of plasma 1,25(OH)2D3 concentration by calcium intake in rat pups.
    Clark SA; Boass A; Toverud SU
    Bone Miner; 1986 Jun; 1(3):193-203. PubMed ID: 3508725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of oral CaCO3 loading and dietary calcium deprivation on plasma 1,25-dihydroxyvitamin D concentrations in healthy adults.
    Adams ND; Gray RW; Lemann J
    J Clin Endocrinol Metab; 1979 Jun; 48(6):1008-16. PubMed ID: 571872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.